Capital Investment Counsel, LLC

Position in MRK — Merck & Co., Inc.

CIK 2033609 DENVER, CO

Position in MRK

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$262,268

+$16,757 QoQ

Shares Held

2,041

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#3,292

of 3,769 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Capital Investment Counsel, LLC holds $30,068,995 across 6 Drug Manufacturers - General names. MRK ranks #6 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	49,388	$12,427,996
2	AMGN	Amgen Inc	20,071	$7,268,110
3	GILD	Gilead Sciences, Inc.	49,570	$6,262,673
4	LLY	ELI LILLY & Co	2,935	$3,520,327
5	JNJ	Johnson & Johnson	1,290	$327,621
6	MRK	Merck & Co., Inc. This page	2,041	$262,268

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$262,268	2,041	0.0%	Shares	Sole	2026-07-15
2026-03-31	$245,511	2,041	+1.1%	Shares	Sole	2026-04-23
2025-12-31	$212,414	2,018	-24.6%	Shares	Sole	2026-02-02
2025-03-31	$240,377	2,678	-49.9%	Shares	Sole	2025-05-15
2024-12-31	$531,322	5,341	-90.2%	Shares	Sole	2025-01-23
2024-09-30	$6,206,054	54,650	+2.8%	Shares	Sole	2024-11-12
2024-06-30	$6,583,065	53,175	+5.3%	Shares	Sole	2024-08-14
2024-03-31	$6,664,530	50,508	+73.2%	Shares	Sole	2024-08-14
2023-12-31	$3,179,132	29,161	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.